Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct.
The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer ...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jemperli (dostarlimab) for adults with stage ...
Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the ...
Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed ...
In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the ...
Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable ...
In this episode of CURE’s Cancer Search Bar, psycho-oncologist Ramy Sedhom, section chief of oncology and palliative care and co-leader of psychosocial oncology services at Penn Medicine Princeton ...
Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and ...
Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...
The trial added 177Lu-PNT2002 to stereotactic body radiation therapy (SBRT) and found that median progression-free survival ...
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch. Beyond the headline Presidential Symposium sessions, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results